Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Viz-Lasheras, S; Gómez-Carballa, A; Bello, X; Rivero-Calle, I; Dacosta, AI; Kaforou, M; Habgood-Coote, D; Cunnington, AJ; Emonts, M; Herberg, JA; Wright, VJ; Carrol, ED; Paulus, SC; Zenz, W; Kohlfürst, DS; Schweintzger, N; Van, der, Flier, M; de, Groot, R; Schlapbach, LJ; Agyeman, P; Pollard, AJ; Fink, C; Kuijpers, TT; Anderson, S; Von, Both, U; Pokorn, M; Zavadska, D; Tsolia, M; Moll, HA; Vermont, C; Levin, M; Martinón-Torres, F; Salas, A, , EUCLIDS, PERFORM, and, DIAMONDS, consortia.
A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatment.
Nat Commun. 2025; 16(1): 673 Doi: 10.1038/s41467-025-55932-9 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Co-authors Med Uni Graz
Kohlfürst Daniela
Schweintzger Nina
Zenz Werner
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Mycoplasma pneumoniae causes atypical pneumonia in children and young adults. Its lack of a cell wall makes it resistant to beta-lactams, which are the first-line treatment for typical pneumonia. Current diagnostic tests are time-consuming and have low specificity, leading clinicians to administer empirical antibiotics. Using a LASSO regression simulation approach and blood microarray data from 107 children with pneumonia (including 30 M. pneumoniae) we identify eight different transcriptomic signatures, ranging from 3-10 transcripts, that differentiate mycoplasma pneumonia from other bacterial/viral pneumonias with high accuracy (AUC: 0.84-0.95). Additionally, we demonstrate that existing signatures for broadly distinguishing viral/bacterial infections and viral/bacterial pneumonias are ineffective in distinguishing M. pneumoniae from viral pneumonia. The new signatures are successfully validated in an independent RNAseq cohort of children with pneumonia, demonstrating their robustness. The high sensibility of these signatures presents a valuable opportunity to guide the treatment and management of M. pneumoniae pneumonia patients.
Find related publications in this database (using NLM MeSH Indexing)
Humans - administration & dosage
Pneumonia, Mycoplasma - drug therapy, microbiology, diagnosis, genetics
Mycoplasma pneumoniae - genetics, isolation & purification
Child - administration & dosage
Transcriptome - genetics
Child, Preschool - administration & dosage
Female - administration & dosage
Male - administration & dosage
Anti-Bacterial Agents - therapeutic use, pharmacology
Adolescent - administration & dosage
Gene Expression Profiling - methods
Infant - administration & dosage
Pneumonia, Viral - virology, diagnosis, drug therapy

© Med Uni GrazImprint